Cefazolin in the treatment of gonorrhea.
D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D002512:Cephalothin / Q000494:pharmacology; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D011339:Probenecid / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D002509:Cephaloridine; D011339:Probenecid; D002512:Cephalothin